Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin

Cancer Lett. 2008 Jun 28;265(1):45-54. doi: 10.1016/j.canlet.2008.02.008. Epub 2008 Apr 18.

Abstract

It is well known that suramin influences proliferation and differentiation of tumour cells. To study whether and how suramin effects osteosarcoma (OS) cells, proliferation, differentiation, LOX mRNA expression and telomerase activity (TA) was analysed in the human MG-63 and U-2 OS, and the rat UMR-106 OS cell lines. Data show that suramin inhibited proliferation in the human cell lines and upregulated alkaline phosphatase activity. TA was attenuated in the human cells while in UMR-106 it was not changed. In UMR-106 suramin had no influence on osteocalcin and LOX expression, in the human cells however, both genes were upregulated.

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Cell Differentiation / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Humans
  • Osteoblasts / drug effects*
  • Osteoblasts / physiology
  • Osteocalcin / biosynthesis
  • Osteosarcoma
  • Protein-Lysine 6-Oxidase / biosynthesis*
  • RNA, Messenger / biosynthesis*
  • Rats
  • Suramin / pharmacology*
  • Telomerase / metabolism
  • Up-Regulation

Substances

  • Anticarcinogenic Agents
  • RNA, Messenger
  • Osteocalcin
  • Suramin
  • Protein-Lysine 6-Oxidase
  • Telomerase
  • Alkaline Phosphatase